MannKind Earnings
NASDAQ: MNKDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.08
MannKind earnings summary
MannKind is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.08. In its most recent report on Aug 5, 2026 (Q2 2026), MNKD posted EPS of $-0.06. Revenue for the quarter was $109.4 million.
Across the last 16 reports, MNKD shares moved an average of 8.6% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
MNKD earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $-0.06 | — | -6.3% |
| May 6, 2026 | — | $-0.05 | — | -12.2% |
| Feb 26, 2026 | — | $-0.05 | — | -20.4% |
| Nov 5, 2025 | — | $0.03 | — | -10.1% |
| Aug 6, 2025 | — | $0.00 | — | +6.0% |
| May 8, 2025 | — | $0.04 | — | -4.2% |
| Feb 26, 2025 | — | $0.03 | — | -6.7% |
| Nov 7, 2024 | — | $0.04 | — | -7.5% |
| Aug 7, 2024 | — | $-0.01 | — | +1.8% |
| May 8, 2024 | — | $0.04 | — | +6.2% |
| Feb 27, 2024 | — | $0.01 | — | +17.1% |
| Nov 7, 2023 | — | $0.01 | — | +10.8% |
| Aug 7, 2023 | — | $-0.02 | — | -5.1% |
| May 9, 2023 | — | $-0.04 | — | +9.2% |
| Feb 23, 2023 | — | $-0.07 | — | -10.0% |
| Nov 8, 2022 | — | $-0.06 | — | -4.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.